
Oncology Institute Inc (TOI) receives an Outperform rating from Noble Capital Markets
In a filing, Oncology Institute Inc revealed its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
In a filing, Oncology Institute Inc revealed its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Oncology Institute Inc revealed its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oncology Institute
In a filing, Oncology Institute Inc revealed its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oncology Institute
Oncology Institute Inc’s recently made public that its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Oncology Institute Inc’s recently made public that its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million
Oncology Institute Inc’s recent filing unveils that its Director M33 Growth I L.P. unloaded Company’s shares for reported $2.05 million